These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 482107)

  • 1. [Side effect of levamisole during Crohn's disease].
    Dupas JL; Capron JP; Delamarre J; Lorriaux A
    Nouv Presse Med; 1979 Apr; 8(16):1350-1. PubMed ID: 482107
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary effects of levamisole in Crohn's disease].
    Villand J; Carli H
    Nouv Presse Med; 1979 Nov; 8(45):3753. PubMed ID: 534237
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe acute polyarthropathy associated with levamisole therapy in a patient with Crohn's disease.
    Benfield GF; Felix-Davies DD; Thompson RA; Asquith P
    Eur J Rheumatol Inflamm; 1984; 7(2):63-5. PubMed ID: 6571261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary effects of levamisole in Crohn disease].
    Villand J; Carli H
    Nouv Presse Med; 1979 Oct; 8(40):3271. PubMed ID: 534191
    [No Abstract]   [Full Text] [Related]  

  • 5. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.
    Sachar DB; Rubin KP; Gumaste V
    Am J Gastroenterol; 1987 Jun; 82(6):536-9. PubMed ID: 3554991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole induced granulocytopenia and thrombocytopenia in a case of Crohn's colitis.
    Sategna-Guidetti C; Peyre S
    Gastroenterol Clin Biol; 1979 Jan; 3(1):104. PubMed ID: 437394
    [No Abstract]   [Full Text] [Related]  

  • 7. [Erythema nodosum and Crohn's disease].
    Areias E; García E Silva L
    Med Cutan Ibero Lat Am; 1984; 12(6):489-95. PubMed ID: 6152299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levamisole-induced arthritis in Crohn's disease.
    Segal AW; Pugh SF; Levi AJ; Loewi G
    Br Med J; 1977 Aug; 2(6086):555. PubMed ID: 890414
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema nodosum as an early sign of Crohn's disease.
    van der Velden JJ; van Marion AM; Kremer B; Straetmans JM; Henquet CJ; Frank J
    Int J Dermatol; 2007 Nov; 46 Suppl 3():27-9. PubMed ID: 17973885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective neutrophil chemotaxis corrected by levamisole in Crohn's disease.
    Patrone F; Dallegri F; Sacchetti C
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):322-3. PubMed ID: 696210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Crohn's disease of the colon treated with high doses of levamisole].
    Tixier P; Verger JB; Rabia M; Bardeche P; Brodi L
    Nouv Presse Med; 1978 Dec; 7(43):3942. PubMed ID: 733561
    [No Abstract]   [Full Text] [Related]  

  • 13. [Letter: Crohn's disease and levamisole].
    Bertrand J; Renoux G; Renoux M; Palat A
    Nouv Presse Med; 1974 Oct; 3(35):2265. PubMed ID: 4617861
    [No Abstract]   [Full Text] [Related]  

  • 14. Levamisole in Crohn's disease--a double-blind controlled trial.
    Wesdorp E; Schellekens PT; Weening RS; Meuwissen SG; Tytgat GN
    Digestion; 1978; 18(3-4):186-91. PubMed ID: 367851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasmapheresis in extra-intestinal manifestations of Crohn's disease].
    Dittrich C; Graninger W; Lenzhofer R; Lochs H; Abel-Telkes B
    Wien Klin Wochenschr; 1984 Sep; 96(18):679-84. PubMed ID: 6335322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of inflammatory joint and spine manifestations in Crohn's disease.
    Münch H; Purrmann J; Reis HE; Bertrams J; Zeidler H; Stolze T; Miller B; Korsten S; Cremers J; Strohmeyer G
    Hepatogastroenterology; 1986 Jun; 33(3):123-7. PubMed ID: 3488946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrent dermohypodermatitis and edematous pancreatitis preceding the digestive manifestations of Crohn's disease].
    Jeanmougin M; Janier M; Leibowitch M; Ribrioux A; Cavelier-Balloy B; Florent C; Laroche L; Civatte J
    Ann Dermatol Venereol; 1984; 111(8):709-10. PubMed ID: 6529092
    [No Abstract]   [Full Text] [Related]  

  • 18. Two first degree relatives with dilatation of the colon due to Crohn's disease.
    Mallinson CN; Candy JC; Cowan R; Prior A
    Guys Hosp Rep; 1973; 122(3-4):211-20. PubMed ID: 4376100
    [No Abstract]   [Full Text] [Related]  

  • 19. Levamisole in cases of E.N.L.
    Arora SK; Singh G; Sen PC
    Indian J Lepr; 1985; 57(1):17-21. PubMed ID: 3897404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levamisole in the treatment of Crohn's disease.
    Segal AW; Levi AJ; Loewi G
    Lancet; 1977 Aug; 2(8034):382-5. PubMed ID: 70591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.